Contract Manufacturing

Merck looks to CMOs to help ease vaccine supply bottleneck

20-Jan-2020 By Nick Taylor

Merck enlists CMOs to help increase Gardasil manufacturing capacity in response to rising demand.

Surging local demand drives 24% growth of Korean contract service sector

15-Jan-2020 By Nick Taylor

South Korean contract service market grows 24% as local biopharma companies step up spending.

Yposkesi doubles manufacturing footprint to meet AAVs growing demand

14-Jan-2020 By Vassia Barba

Yposkesi CDMO announces expansion to cover growing demand, strikes a deal on viral vectors production for a gene therapy development project.

FDA places Innate cancer trial on partial clinical hold over CMO issue

14-Jan-2020 By Nick Taylor

The US FDA puts Innate Pharma trial on partial clinical hold after learning of CMO problems.

WuXi Biologics and Almirall partner to develop dermatological treatments

09-Jan-2020 By Vassia Barba

Almirall enters drug discovery agreement with WuXi Biologics, gaining access to the WuXiBody platform to develop antibodies for the treatment of dermatological diseases.

CMO problems prompt Innate to put trial on partial hold

24-Dec-2019 By Nick Taylor

Innate Pharma stops dosing new patients in clinical trial amid problems at manufacturing partner.

3M set to sell biopharma-focused CDMO for $650m

23-Dec-2019 By Nick Taylor

3M agrees to sell drug delivery contract service unit to investment group Altaris Capital Partners.

Avid frames Halozyme setback as potential positive for CDMO business

19-Dec-2019 By Nick Taylor

Avid Bioservices sees potential upside to clinical development setback at big customer Halozyme.

Sanofi to 'optimize' CMOs to drive down spending

18-Dec-2019 By Nick Taylor

Sanofi plans “optimization of CMOs and suppliers” as new CEO targets €2bn in savings by 2022.

Antibe engages global CMO to support planned pain drug partnership

16-Dec-2019 By Nick Taylor

Antibe tasks global CMO with providing a reliable supply of pain drug, ATB-346.

Ex-Covance CEO Ratliff takes over as head of AMRI

13-Dec-2019 By Nick Taylor

Ex-Covance leader John Ratliff replaces Michael Mulhern as CEO of AMRI.

Novartis sets 2020 target for commercial readiness of cell therapy CMO

10-Dec-2019 By Nick Taylor

Novartis aims to have its Japanese cell therapy CMO commercially ready in the second half of 2020.

BerGenBio taps into Piramal’s platform to develop leukemia treatment

09-Dec-2019 By Vassia Barba

Piramal to support the development of BerGenBio’s treatment for acute myeloid leukemia, after the US FDA granted the candidate fast track designation.

GE Healthcare launches automation software for CAR-T manufacturing

05-Dec-2019 By Vassia Barba

GE Healthcare tops its C-Pro cell processing system with SpinOculation, an automation software that enables closed T cells transduction at the preferred volume and concentration.